Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOA-04: Radiotherapy vs Chemotherapy in Anaplastic Glioma
NCT00717210Phase 3Completed
- Sponsor
- Neuro-Oncology Working Group of the German Cancer Society
- Start
- Jun 1999
- Primary completion
- Feb 2005
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide, procarbazine, lomustine, vincristine in anaplastic glioma, anaplastic astrocytoma (AA), Oligodendroglioma (OG), oligoastrocytoma, sponsored by Neuro-Oncology Working Group of the German Cancer Society. Started Jun 1999; status: completed.
02
Drugs
temozolomideprocarbazinelomustinevincristine
03
Conditions
anaplastic gliomaanaplastic astrocytoma (AA)Oligodendroglioma (OG)oligoastrocytoma
Beyond the preview
Go deeper on NCT00717210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717210.